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Mycophenolate mofetil prevents arteriolopathy and renal in- The mechanisms involved in the progression of renal
jury in subtotal ablation despite persistent hypertension. disease to end-stage renal failure are incompletely un-
Background. Although renal protective effect of interrupting derstood. Clinical studies have shown that hypertension
the inflammatory process is well established, it is still controver- and proteinuria are closely associated with progression tosial if it also prevents the glomerular hemodynamic distur-
chronic renal disease [1, 2]. In clinical and experimentalbances that initiate renal injury. We investigated the effects of
studies, therapies that lower blood pressure and reducesuppressing inflammation with mycophenolate mofetil (MMF)
on glomerular hemodynamics, arteriolar structural changes, proteinuria effectively retard progression, especially drugs
and renal histologic injury in rats with subtotal renal ablation that interfere with the effects of angiotensin II (Ang II)
Methods. Micropuncture studies were performed 30 days [1–5]. Hemodynamic stress induced by glomerular hy-
after 5/6 nephrectomy in rats untreated and treated with MMF pertension and hypertrophy are thought to be initiating(30 mg/kg/day). Renal histology, immunohistochemistry for
factors [6]. In addition, proteinuria resulting from in-lymphocytes, macrophages and inducible nitric oxide synthase
creased glomerular capillary pressure and glomerular(iNOS) expression, as well as afferent arteriolar (AA) morpho-
barrier dysfunction produces proximal tubule proteinmetry was evaluated.
Results. Renal ablation significantly increased proteinuria overload inducing proliferation and inflammatory cells
(6.8 to 82.7 mg/day), mean arterial pressure (MAP) (120 to 166 infiltration [7].
mm Hg), single-nephron glomerular filtration rate (SNGFR) There is growing evidence that inflammation plays a
(34.8 to 56.3 nL/min), glomerular plasma flow (QA) (117.7 to
critical role in the progression of renal injury, even when246.9 nL/min), and glomerular capillary pressure (PGC) (48.9
the initiating insult is not mediated by immunologic factors,to 61.0 mm Hg). Afferent resistance (AR), efferent resistance,
such is the case in renal lesion associated with Ang II-and ultrafiltration coefficient remained unchanged. Despite
persisting arterial hypertension (152 mm Hg), MMF prevented mediated hypertension in double transgenic rats [8, 9],
proteinuria (13.3 mg/day), and significantly reduced SNGFR subtotal renal ablation [10, 11], and other models [12–15].
(44.4 nL/min), PGC (49.1 mm Hg), and QA (163.2 nL/min) In double transgenic rats for human renin and angioten-
due to a rise in AR (3.13 vs. 2.18 1010 dyn/sec/cm5). Glomerular
sinogen genes, characterized by high levels of Ang II, se-sclerosis, tubulointerstitial damage, lymphocyte and macro-
vere hypertension, intense proteinuria and renal damage,phage infiltration, and iNOS expression were significantly re-
Muller et al [8] demonstrated that renal injury is associ-duced by MMF, in addition hypertrophy of AA resistance
evaluated by the media/lumen ratio was prevented (P 0.001). ated with activation of nuclear factor-kappa B (NF-B),
Conclusions. Reduction in proteinuria, SNGFR, QA, and overexpression of NF-B-dependent proinflammatory
PGC, despite elevated MAP, indicate preservation of AA func- cytokines, chemokines, and adhesion molecules, and in-
tion. These results suggest that inflammation associated arte-
flammatory cells infiltration. Inhibition of NF-B activa-riolopathy of AA contributes to glomerular hemodynamic dis-
tion with different maneuvers [8, 9, 16] prevented pro-turbances that participate in the progression of renal disease.
teinuria and greatly attenuated renal damage, despite
persisting hypertension. These observations suggest that
in hypertension-induced renal injury, the inflammatoryKey words: glomerular hemodynamics, arteriolopathy, mycophenolate
mofetil, 5/6 nephrectomy, inflammation. process plays a predominant role, however, it is not
known from these studies if suppression of inflammationReceived for publication June 14, 2002
also prevented the glomerular hemodynamic changesand in revised form September 6, 2002
Accepted for publication November 16, 2002 that initiates injury or if renal injury was attenuated
despite persistence of these alterations. 2003 by the International Society of Nephrology
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Several recent studies in rats with extensive renal abla- METHODS
tion evaluated the role of inflammation by suppressing Experimental design
inflammatory cells infiltration with different drugs [10, Studies were carried out in male Sprague-Dawley rats
11, 17–20]. Administration of mycophenolate mofetil weighing 250 to 300 g. Three experimental groups were
(MMF), an immunosuppressive drug that exerts a selec- studied: (1) the group sham included nine sham-oper-
tive antiproliferative activity on activated B and T cells ated rats; (2) the group with a 5/6 nephrectomy included
and inhibits glycosylation of adhesion molecules [21], 11 rats with 5/6 renal mass reduction, which were studied
prevented lymphocyte and macrophage proliferation 30 days after renal ablation; and (3) group 5/6 nephrec-
and infiltration and reduced progressive renal damage tomy/MMF consisted of 12 rats with 5/6 renal mass reduc-
[10, 11, 17, 20]. In every study, the beneficial effects tion that received MMF (5/6 Nx/MMF; F. Hoffman-La
of MMD treatment occurred despite the persistence of Roche, Basel, Switzerland) at a dose of 30 mg/kg/day by
systemic hypertension and, in some studies, despite per- gastric gavage for 30 days and then were studied.
sistence of proteinuria, suggesting that they were not Twenty additional rats had 5/6 nephrectomy and were
mediated by amelioration of glomerular hemodynamic divided in four groups of five rats each, two groups re-
disturbances responsible for the initiation of renal injury ceived vehicle (5/6 nephrectomy) and two groups re-
[10, 11, 17, 20]. Remuzzi et al [20] found that MMF ceived MMF (5/6 nephrectomy/MMF). One set of 5/6
effect was independent of hypertension and proteinuria, nephrectomy and 5/6 nephrectomy/MMF was used for
Fujihara et al [10] measured glomerular pressure and light microscopy studies and for the immunohistologic
found that the rise in glomerular pressure was not analysis of the infiltrating lymphocytes and macrophages
changed after 4 weeks of MMF therapy. However, after and the other set was used to evaluate inducible nitric
oxide synthase (iNOS) expression. Rats were sacrificed8 weeks when rats had considerably higher values of
at 30 daysglomerular pressure, MMF therapy was associated with
partial reduction of glomerular capillary pressure (PGC)
Renal mass reductionand proteinuria [17]. On the other hand, we recently
Under anesthesia with sodium pentobarbital, 30 mg/kgtreated rats with subtotal renal ablation with polysul-
intraperitoneally, renal ablation was performed by re-phate pentosan (PPS), a heparinoid with anti-inflamma-
moval of the right kidney and selective infarction oftory effects and found that, despite persisting hyperten-
approximately two thirds of the left kidney by ligation ofsion, PPS prevented proteinuria, reduced inflammatory
two or three branches of the renal artery. Sham operationcells infiltration, and significantly attenuated renal injury.
consisted of ventral laparotomy and manipulation of theEvaluation of glomerular hemodynamics reveled nor-
kidneys and renal pedicle without destruction of renalmalization of glomerular hypertension and hyperfiltra-
tissue. Micropuncture studies were performed 30 daystion due to a rise in afferent arteriolar (AA) resistance
after the surgical procedure.[19]. These results suggested that suppression of in-
Systolic blood pressure was measured in conscious,flammation improved arteriolar functional capacity to
restrained rats by tail-cuff pletysmography (Narco Bio-prevent excessive transmission of arterial pressure to
systems, Austin, TX, USA). Rats were conditioned twiceglomerular capillaries due to prevention of vascular le-
before the blood pressure was measured at basal period,
sions associated to renal injury.
every week during the first 2 weeks and every 2 weeks
Thus, although the renal protective effect of inter- for the rest of the study.
rupting the inflammatory process by different maneuvers A series of 24-hour urine collections for proteinuria
is well established, it is still controversial if it also pre- were collected in metabolic cages with ad libitum food
vents the glomerular hemodynamic disturbances respon- and water intake in the basal period and at 29 days of
sible for the initiation of renal injury. the study before the micropuncture experiments.
This possibility should be further investigated because
the renoprotective effect suppressing inflammation in Micropuncture studies
nonimmune renal injury could be partially due to im- Rats were anesthetized with sodium pentobarbital (30
provement in glomerular hypertension and hyperfiltra- mg/kg body weight intraperitoneally), and supplemen-
tion in remnant nephrons as a consequence of preventing tary doses were instilled as required. The rats were placed
arteriolar lesions. on a temperature-regulated micropuncture table at 37C.
Therefore, in this study we evaluated the effects of Polyethylene tubing was used to catheterize the trachea
suppressing the inflammatory process with MMF on the (PE-240), both jugular veins, femoral arteries (PE-50),
glomerular hemodynamic pattern, arteriolar structural and the left ureter (PE-10). The left kidney was exposed
changes, and renal histologic injury in rats with subtotal and placed in a Lucite holder, which was sealed, covering
the kidney surface with Ringer’s solution. Mean arterialrenal ablation.
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pressure (MAP) was continuously monitored with a scribed initially by Raij, Azar, and Keane [27] and used
by us in previous communications [28]: grade 0  nopressure transducer (Model p23 Db, Gould, Hato Rey,
Puerto Rico, USA) and recorded on a polygraph (Grass sclerosis, grade 1  25% of the glomerulus, grade 2 
25% to 50% of the glomerulus, grade 3  50% to 75%Instruments, Quincy, MA, USA). Blood samples were
taken periodically and replaced with blood from a nor- of the glomerulus, and grade 4  75% to 100% of the
glomerulus. The score of a biopsy was calculated by themal donor rat.
Rats were maintained euvolemic by infusion of iso- equation: [(1  number glomeruli with grade 1)  (2 
number glomeruli with grade 2)  (3  number glomer-tonic rat plasma (10 mL/kg body weight) during surgery,
followed by an infusion of 5% polyfructosan, 2.2 mL/ uli with grade 3)  (4  number glomeruli with grade
4)]  100/total number of glomeruli examined.hour (Inutest, Laevosan-Gesellschaft, Austria), and 0.9%
sodium saline solution, as vehicle. After 60 minutes, six Tubulointerstitial lesions (dilatation, atrophy, cellular
infiltration, and fibrosis) were graded on a scale of 0 totimed samples of tubule fluid were collected from surface
proximal convolutions for determination of flow rate and 5, as described in a previous work [5]: 0  changes in
less than 10% of the section, 1 changes in up to 20%polyfructosan concentration; intratubular hydrostatic pres-
sure under free flow and stop flow conditions and peritu- of the section, 2  changes in up to 40% of the section,
3 changes in up to 40% of the section, 4 changesbular capillary pressure were measured with a servo-null
device (Servo Nulling Pressure System, Instrumentation in up to 80% of the section, and 5  changes in more
than 80% of the section. Ten to 15 sections were exam-for Physiology and Medicine, Inc., San Diego, CA, USA)
as previously described [5]. Polyfructosan was measured ined in each biopsy and the average score was used as
the score of the biopsy.in plasma and urine samples. Glomerular colloid osmotic
pressure was estimated in protein from blood taken from Quantification of afferent arterioles morphology: Ar-
teriolar morphology was assessed by indirect peroxidasethe femoral artery (CA) and surface efferent arterioles (CE).
immunostaining for -smooth muscle actin (-SMA)
Analytical procedures (DAKO Corp., Carpinteria, CA, USA). Quantifications
were performed blinded. Only vessels adjacent to glo-Polyfructosan concentrations in plasma and urine were
determined by the macro-anthrone method of Davidson meruli in the outer cortex were selected. AAs were dis-
tinguished from efferent arterioles by the presence of anand Sackner [22]. The volume of fluid collected from indi-
vidual proximal tubules was estimated from the length internal elastic lamina and by thin, flattened endothelial
cells [29]. Using immersion-fixed tissue, AA wall thick-of the fluid column in a constant bore capillary tube of
known internal diameter. The concentration of tubular ness was measured by computer image analysis (Image-
Pro-Plus) as previously described [29, 30]. For each arte-polyfructosan was measured by the microfluorescence
method of Vureck and Pegram [23]. Protein concentra- riole, the outline of the vessel and its internal lumen
(excluding the endothelium) was generated using com-tions in afferent and efferent samples were determined
by the method of Viets et al [24]. Protein concentrations puter analysis to calculate the total medial area (outline-
inline), in ten arterioles per biopsy. Vessels that werein urine were determined by the method of sulfosalicylic
acid [25]. cross-sectioned or not sectioned transversally, providing
an asymmetric wall, were excluded from the presentGlomerular filtration rate (GFR), single-nephron glo-
merular filtration rate (SNGFR), calculated glomerular study. The media-lumen ratio was calculated by the out-
line/inline relationship. [29, 30]. Although perfusion-capillary hydrostatic pressure (PGC), glomerular capillary
hydrostatic pressure gradient (	P), single-nephron fil- fixed tissue is preferred for morphometric measurements
[31], immersion-fixed tissue is acceptable for measuringtration fraction (SNFF), single-nephron plasma flow
(QA), single-nephron blood flow (SNBF), afferent (AR) medial thickness [32], and comparisons are valid because
all samples were treated with the same method.and efferent (ER) resistances, ultrafiltration coefficient
(Kf), and oncotic pressure (
) were calculated according
Immunohistologic studiesto equations given elsewhere [5, 26].
Lymphocyte and macrophage infiltration was studied
Histologic studies with the immunoperoxidase technique as described be-
fore [33, 34]. Briefly, tissues were successively washedParaffin-embedded sections were stained with hema-
toxylin-eosin and periodic acid-Schiff (PAS) reagent. and incubated with 20 mL ExtrAvidin, 2.5 mg/mL (Sigma
Chemical Co., St. Louis, MO, USA) and with 30 mLFour micrometer sections were examined by two investi-
gators in a blinded fashion. Glomerulosclerosis was de- 0.001% biotin in phosphate-buffered saline (PBS). Af-
terward, tissues were incubated for 2 hours at 37C withfined as the presence of PAS-stained tissue within the
glomerular tuft, with loss of cellular elements, collapse 50 mL of the corresponding primary monoclonal anti-
body (see later), diluted 1:30 in Tris-saline buffer (TSB),of capillary lumen, and entrapment of hyaline material.
The severity of glomerulosclerosis was classified as de- pH 7.8. After washing in TSB for 15 minutes, tissues
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were incubated for 1 hour with 30 mL rat antimouse
immunoglobulin (IgG) (ab) biotin-conjugated fragments
with minimal cross-reactivity with human, horse, and rat
serum proteins (Accurate Chemical Corp., Westbury,
NY, USA), and finally, for 30 minutes with 60 mL peroxi-
dase-conjugated ExtrAvidin. After a final wash, tissues
were incubated for 15 minutes in diaminobenzidine and
H2O2 in TSB.
The primary antibodies used were anti-CD5 (mouse
monoclonal antirat thymocytes and lymphocytes) and
anti-ED-1 (mouse monoclonal antirat monocytes and
macrophages) were purchased from Biosource Interna-
tional (Camarillo, CA, USA). Results in glomeruli were
expressed as positive cells/glomerular cross-section and
in interstitium as positive cells per millimeter squared.
Inducible NOS expression was evaluated by indirect
streptavidin-biotin-peroxidase technique using anti-iNOS
antibody (DAKO Corp., Carpinteria, CA, USA). Quan-
tifications were performed blinded. Ten noncrossed glo-
meruli fields (100) were analyzed per biopsy in an
Olympus BX51 microscope (Olympus America, Inc.,
Melville, NY, USA). Expression of glomerular iNOS was
evaluated by computer image analysis (Image-Pro-Plus).
Results were expressed as the relationship between the
number of positive cells/number of glomeruli nuclei.
Statistical analysis
Fig. 1. Systolic blood pressure and proteinuria in sham, 5/6 nephrec-Data are expressed as mean  SEM. Data were ana- tomy (5/6 Nx), and 5/6 nephrectomy/mycophenolate mofetil (5/6 Nx/
lyzed by ANOVA for multiple comparison followed by MMF) groups. *P 0.05 vs. sham; †P  0.05 vs. 5/6 Nx vs. 5/6 Nx/MMF.
Bonferroni test as a post hoc procedure. P  0.05 was
considered statistically significant.
In the untreated group there was a 62% increment in
SNGFR versus sham animals (P  0.05). In contrast, theRESULTS
increment of SNGFR in MMF-treated group was onlyRenal ablation resulted in development of severe sys-
27% and did not reach statistical significance (Table 1).tolic hypertension (170 mm Hg) (Fig. 1). Treatment
The increase in SNGFR was the result of the elevation
with MMF was associated with a less pronounced incre- in two of the determinants of GFR, the glomerular
ment in blood pressure but the difference between plasma flow (QA) and the PGC. Thirty days after surgery
treated and untreated groups were not statistically sig- QA had risen by 108% in untreated rats and in MMF-
nificant (Fig. 1). treated rats the increment was only 38% and did not
Subtotal renal ablation induced an elevation in urine reach statistical significance when compared to sham
protein excretion of almost ninefold after 30 days. In group. PGC increased to 61.5  2.5 mm Hg, whereas in
contrast, the urinary protein excretion in the MMF- the MMF-treated rats, PGC did not rise, remaining at
treated rats was not significantly different from sham- values similar to sham group (Table 1). Glomerular over-
operated control rats (Fig. 1). perfusion in rats with renal ablation was the result of
defective constriction of preglomerular vessels to higher
Micropuncture studies arterial pressure, as indicated by the unchanged AA
The results obtained in the micropuncture studies are resistance in the untreated 5/6 nephrectomy group com-
summarized in Table 1. Body weight was not significantly pared to sham animals. In contrast; glomerular hyperper-
different among the studied groups. fusion was prevented in rats treated with MMF due to a
Although whole kidney GFR was comparably reduced 70% higher AA resistance. Thus, in the face of persistent
by renal ablation in the MMF-treated and untreated systemic hypertension, MMF treatment preserved the
groups (Table 1), measurement of single-nephron function capacity of preglomerular vessels to prevent hyperfiltra-
demonstrated marked differences in glomerular adapta- tion and glomerular hypertension in remnant nephrons
(Table 1).tion between untreated rats and those receiving MMF.
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Table 1. Glomerular hemodynamics in rats with 5/6 nephrectomy and 5/6 nephrectomy plus mycophenolate mofetil (MMF)
5/6 Nephrectomy/
Group Sham 5/6 Nephrectomy mycophenolate mofetil
Body weight g 386.19.2 366.39.7 342.711.7
Kidney weight g 1.600.06 1.780.16 1.750.15
Mean arterial pressure mm Hg 119.62.9 165.85.4a 152.54.9a
Glomerular filtration rate mL/min 1.170.05 0.430.09a 0.470.07a
Single-nephron filtration fracture % 0.300.02 0.250.02 0.280.01
Single-nephron glomerular filtration rate nL/min 34.82.7 56.34.2a 44.42.6
Glomerular plasma flow nL/min 117.710.4 246.935.0a 163.213.3
Glomerular capillary pressure mm Hg 48.91.6 61.02.5a 49.11.0
Afferent resistance 1010 dyn/s/cm5 2.450.14 2.180.30b 3.130.25
Efferent resistance 1010 dyn/s/cm5 1.540.14 1.240.22 1.360.10
Ultrafiltration coefficient nL/s/mm Hg 0.0370.003 0.0380.004 0.0470.004
aP  0.05 vs. sham; bP  0.05 vs. 5/6 nephrectomy/mycophenolate mofetil
Table 2. Glomerular histology and immunohistology 30 days after surgery
5/6 Nephrectomy/
Sham 5/6 Nephrectomy mycophenolate mofetil
Glomerular volume m3  106 1.610.10 2.380.7a 2.480.7a
Glomerular sclerosis score, 0 to 400 1.32.0 104.430.0c 29.29.9b,e
Tubulointerstitial score 0 to 5 00 2.900.8c 0.710.9e
CD5-positive cells/mm2 0.20.3 13764.2c 5939.3a,d
ED-1-positive cells/mm2 0.70.1 19461.2c 349.6e
a P  0.05 vs. sham; bP  0.01 vs. sham; c P  0.001 vs. sham; d P  0.01 vs. 5/6 nephrectomy; eP  0.001 vs. 5/6 nephrectomy
Finally, the Kf and ER were not significantly different In contrast to the findings in glomeruli, tubulointersti-
tial infiltration of lymphocytes (CD5-positive cells) andamong the studied groups.
macrophages (ED-1-positive cells) in the remnant kid-
Histologic examination ney of the untreated 5/6 nephrectomy group was in-
creased three to six times. MMF treatment reduced dras-The histologic analysis is shown in Table 2. Glomerular
volume was larger in the group of rats with renal mass tically the inflammatory infiltrate (Table 2, Fig. 4).
reduction. There were no significant differences in the Finally, the expression of glomerular iNOS, which is
glomerular hypertrophy in the 5/6 nephrectomy group a marker of inflammation and macrophage activation,
and the 5/6 nephrectomy/MMF group. As expected, glo- was significantly reduced by MMF, from 1.0  0.2 vs.
merular sclerosis increased significantly in severity 30 0.45  0.1, P  0.05 (Fig. 4).
days following renal ablation and MMF treatment re-
sulted in an almost fourfold reduction in sclerosis scores
DISCUSSIONin the 5/6 nephrectomy/MMF group (Table 2).
The renal protective effect of interrupting the in-AAs appeared hypertrophic and there was narrowing
flammatory process without lowering arterial pressure isof the lumen due to thickening of the arterial wall. Analy-
well established [10, 11, 17–20]. It is still controversial,sis of AA morphology by immunostaining for -SMA
however, if suppression of inflammation also preventsdemonstrated significant hypertrophy in the 5/6 nephrec-
the hemodynamic disturbances that initiate renal dam-tomy group, as indicated by a higher media/lumen ratio
age. Vascular injury is a constant finding in inflammatorythan sham (6.6  0.9 vs. 3.4  0.2, P  0.01), which was
renal lesions [12, 14, 35, 36], and glomerular hemody-prevented in rats treated with MMF (2.8  0.2, P 
namic changes are determined to a great extent by the0.001, Figs. 2 and 3).
functional capacity of preglomerular arterioles. Thus, theIntraglomerular lymphocytes (CD5-positive cells/glo-
renoprotective effect exerted by anti-inflammatory maymerular cells) were also reduced with MMF treatment
be partially mediated by an improvement of glomerularbut the results were not statistically significant (5/6 ne-
hemodynamics resulting from amelioration of AA dam-phrectomy 0.11 0.12, 5/6 nephrectomy/MMF 0.03
age. Accordingly, we decided to investigate the role of0.07). Similar findings were obtained with intraglomeru-
inflammation on vascular injury and glomerular hemody-lar macrophage (ED-1-positive cells/gcs) in the experi-
namics in rats with subtotal renal ablation, a model ofmental groups (5/6 nephrectomy  0.22  0.25, 5/6 ne-
phrectomy/MMF  0.04  0.08). nonimmune renal damage.
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Fig. 2. Afferent arteriole morphology in rem-
nant kidney tissue. (A ) and (B ), sham rat.
(C ) and (D ), 5/6 nephrectomy untreated rat
at 30 days. (E ) and (F ), 5/6 nephrectomy/
mycophenolate mofetil (MMF)-treated rat at
30 days. (B), (D), and (F) stained with Ab
anti--smooth muscle actin (a-SMA). Arteri-
olar hypertrophy in 5/6 nephrectomy rats was
prevented in MMF-treated rats (100). (Repro-
duction of this figure in color was made possible
by Roche Mexico, Mexico City, Mexico.)
tions demonstrated glomerular hypertension (12.1
mm Hg) and hyperfiltration (61.8%) in remnant neph-
rons. Treatment with MMF, suppressed inflammation as
indicated by a significant reduction in CD5-positive and
ED-1-positive cells and a decrease of glomerular expres-
sion of iNOS, an inflammation marker.
An important observation was that, despite persisting
arterial hypertension, glomerular hemodynamic distur-
bances were largely prevented. Indeed, glomerular pres-
sure was normalized and glomerular hyperfiltration was
reduced to only 20.7%. Similarly, the rise in glomerular
plasma flow was significantly attenuated. These changes
were due to a higher afferent resistance and suggestFig. 3. Afferent arteriole media/lumen ratio in sham, 5/6 nephrectomy
(5/6 Nx), and 5/6 nephrectomy/mycophenolate mofetil (5/6 Nx/MMF) that functional capacity of preglomerular vessels was
groups. *P  0.01 vs. sham; †P  0.001 vs. 5/6 Nx vs. 5/6 Nx/MMF. preserved.
Recently, Fujihara et al [10, 17] studied Munich-Wistar
rats and evaluated glomerular hemodynamics by measur-
ing whole kidney function and directly measuring glo-The results of the present study confirmed that exten-
merular pressure in superficial cortical glomeruli. In con-sive renal mass ablation is associated with severe arterial
trast to our results, they found that 4 weeks after renalhypertension, massive proteinuria, and significant glo-
ablation, glomerular hypertension was not changed bymerular and tubulointerstitial lesions with lymphocyte
and macrophage infiltration. Micropuncture determina- MMF therapy [10]. However, in a second study in which
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Fig. 4. Immunohistology showing the rem-
nant kidney tissue stained with Ab anti-CD5
(A ) and (B ), ED-1 (C ) and (D ) and inducible
nitric oxide synthase (iNOS) (E ) and (F ). (A),
(C), and (E) are 5/6 nephrectomy-untreated
rats. (B), (D), and (F) are 5/6 nephrectomy/
mycophenolate mofetil (MMF)-treated rats.
MMF treatment reduced interstitial infiltra-
tion of lymphocytes and macrophages and sup-
pressed iNOS expression in glomeruli. (Repro-
duction of this figure in color was made possible
by Roche Mexico, Mexico City, Mexico.)
rats were evaluated 8 weeks after surgery, when the were not different than those reported by them (61 
2.5 vs. 66  3.0 mm Hg) [10]. In contrast, values aftervalues of glomerular pressure were considerably higher
[17], MMF therapy was associated with partial reduction MMF treatment were unchanged in their studies and
significantly lower in ours (49.1  1 vs, 66  2 mm Hg).of PGC and proteinuria. Treatment with an Ang II AT1
receptor antagonist normalized glomerular pressure and Since their rats tolerated considerable lower doses of
MMF (10 vs. 30 mg/kg), it is conceivable that a lesserreduced proteinuria close to normal [17]. The main dif-
ference with our studies is that we found a clear effect immunosuppressive effect prevented the reduction in
proteinuria and restoration of glomerular hemodynam-of MMF on renal function, evidenced by the reduction in
PGC, SNGFR, and proteinuria, which are independent ics. Moreover, when we used lower doses of MMF (15
mg/kg) in our 5/6 nephrectomy rats proteinuria was notmeasurements that indirectly evaluate glomerular pres-
sure and function. We do not have an obvious explana- prevented (unpublished observations). Moreover, Re-
muzzi et al [20] found in Sprague-Dawley rats with 5/6tion for these discrepancies; however, there are several
possible facts that may contribute to the different results. nephrectomy that the drug greatly limited the accumula-
tion of lymphocytes but, in contrast to our findings, itThe rat strains were different. They used Munich Wistar
rats and we used Sprague-Dawley. PGC was measured had no effect on proteinuria and its effects on histologic
lesions were minimal. They suggest the effect of MMFby different methods. They measured it directly in capil-
laries of superficial glomeruli and we used stop flow was not due to interference with hemodynamic mecha-
nisms of injury. There is no apparent explanation formethod. Previous studies however, demonstrated that
stop flow measurements are valid in rats without super- these discrepancies with our results, except that the dose
of MMF in their study was 33% lower (20 vs. 30 mg/kgficial glomeruli [37–39]. Indeed, the absolute values of
PGC at 4 weeks after 5/6 nephrectomy in our studies given orally). Thus, it appears that higher doses of MMF
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are required to prevent proteinuria and glomerular he- higher doses of MMF prevented both arteriolopathy and
glomerular hypertension.modynamic alterations in addition to suppressing in-
The mechanism by which vascular hypertrophy im-flammatory cells infiltration.
pairs the ability of preglomerular vessels to limit theVascular injury is a constant finding in renal inflam-
transmission of systemic pressure to glomerular capillar-matory lesions, particularly when arterial hypertension
ies is beyond the scope of this study. Nonetheless, it isis present; however, little attention is usually given to
well established that inflammation of the vascular wallthe potential role of vascular lesions in contributing to
plays an important role. Activation of transcription fac-progression of renal damage. Injury of an AA can result
tors, NF-B and activator protein-1 (AP-1) in vascularin glomerular hemodynamic disturbances that induce
smooth muscle cells (VSMC) induces a switch of VSMCproteinuria, which, in turn, can stimulate the inflamma-
to a proliferative phenotype [41]. This change promotestory process, thereby creating a vicious cycle that may
growth and increased synthesis and rearrangement ofcontribute to progression of renal disease. In 5/6 ne-
extracellular matrix proteins and decreases the synthesisphrectomy rats, the rise in PGC results from inappropri-
of contractile proteins, which in turn decrease the re-ate constriction of the AA that allows the transmission
sponse of VSMC to contractile stimulus. [42]. Thus, hy-of the systemic hypertension to the glomerular tuft. In
pertrophy and increase in collagen content of vascularthe present study, histologic examination and morpho-
wall may decrease their ability to contract in responsemetry with image computer analysis showed arteriolopa-
to a rise perfusion pressure. Inhibition of expression ofthy of AAs as disclosed by a significant increase in media/
selectins, VSMC proliferation and collagen depositionlumen ratio indicating hypertrophy of the vessel wall.
by MMF [43–46] would maintain the functional capacityTreatment with MMF attenuated arteriolopathy and
of preglomerular vessels.prevented the rise in glomerular pressure despite per-
sisting systemic hypertension, suggesting that preserva-
tion of vascular structure also preserved vascular func- CONCLUSION
tion as indicated by a higher afferent resistance. Vascular In summary, interrupting inflammation with MMF
resistance is inversely determined by lumen diameter; therapy prevented proteinuria, renal injury, and arte-
however, we cannot evaluate AA luminal changes in riolopathy of AAs. In addition, normal glomerular pres-
our studies because we fixed the kidneys by immersion sure was maintained, despite systemic hypertension, sug-
instead of perfusion fixation. Dissociation of vascular gesting that vascular injury, by perpetuating glomerular
hypertrophy from arterial hypertension has been re- hemodynamic stress may contribute to progression of
ported in several experimental models. Mervaala et al renal disease.
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